SCHEMBL19981546

SCHEMBL19981546

CN(C)CCN(C)c1ccc(Nc2cc(-c3ccc(F)c(NC(=O)C4=CC5=CC=CC=C(C5)S4)c3)nn(C)c2=O)nc1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BTK Q06187 8/20 0.37
MET P08581 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9984405 0.79 BTK (0.48) BTK
SCHEMBL9985483 0.68 BTK (0.48) BTK
SCHEMBL9984396 0.68 BTK (0.47) BTK
SCHEMBL9984789 0.66 BTK (0.43) BTK
SCHEMBL9984564 0.64 BTK (0.41) BTK
SCHEMBL2532115 0.64 BTK (0.41) BTK
SCHEMBL9985165 0.64 BTK (0.41) BTK
SCHEMBL19981913 0.64 NTRK1 (0.38) BTK
SCHEMBL2492181 0.63 BTK (0.61) BTK
SCHEMBL2464623 0.63 BTK (0.42) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2365970-B1 PYRIDAZINONES AND THEIR USE AS BTK INHIBITORS GILEAD CONNECTICUT INC (US) 2018-03-21 EP disclosed